Connect Biopharma Holdings Limited (CNTB) Social Stream



Connect Biopharma Holdings Limited (CNTB): $1.05

0.10 (-8.70%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

Add CNTB to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#251 of 398

in industry

CONNECT BIOPHARMA HOLDINGS LTD (CNTB) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering CONNECT BIOPHARMA HOLDINGS LTD.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-18 3 $32 $27 $30 $1.12 2578.57%
2022-04-08 3 $25 $19 $22 $1.12 1864.29%
2022-05-04 3 $13 $1.5 $7.833 $1.12 599.38%
2022-06-06 4 $13 $1.5 $7.125 $1.12 536.16%
2022-09-15 4 $9 $1.75 $5.687 $1.12 407.77%
2023-02-08 2 $7 $1.75 $5.187 $1.12 363.12%
2023-04-12 3 $7 $1.75 $5.187 $1.12 363.12%
2023-07-11 2 $7 $5 $6.333 $1.12 465.45%
2023-09-12 1 $7 $7 $7 $1.12 525%
2023-09-13 2 $7 $5 $6 $1.12 435.71%

The Trend in the Analyst Price Target


Over the past 22 months, CNTB's average price target has gone down $24.

CNTB reports an average of 480.32% for its upside potential over the past 31 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-08 2 7 1.75 5.187 1.17 343.33%
2023-02-08 4 7 1.75 5.187 1.17 343.33%
2023-04-12 2 7 5.00 6.333 1.12 465.45%
2023-07-11 2 7 5.00 6.333 1.08 486.39%
2023-09-13 2 7 5.00 6.000 0.78 669.23%

CNTB Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 2 0 0 0 0 2

The Trend in the Broker Recommendations


Over the past 22 months, CNTB's average broker recommendation rating improved by 0.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of all US stocks, CONNECT BIOPHARMA HOLDINGS LTD's upside potential (average analyst target price relative to current price) is greater than 1021.56% of them.
  • In the context of all US stocks, CONNECT BIOPHARMA HOLDINGS LTD's number of analysts covering the stock is higher than 79.92% of them.
  • In terms of how CONNECT BIOPHARMA HOLDINGS LTD fares relative to all US stocks, note that its average analyst price target is higher than 114.34% of that group.
  • In terms of how CONNECT BIOPHARMA HOLDINGS LTD fares relative to Healthcare stocks, note that its variance in analysts' estimates is lower than -479.13% of that group.

In the Pharmaceutical Products industry, LVTX, EWTX, and DSGN are the three stocks most similar to CONNECT BIOPHARMA HOLDINGS LTD regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding CNTB using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!